These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19366571)

  • 21. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
    Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.
    Westritschnig K; Hochreiter R; Wallner G; Firbas C; Schwameis M; Jilma B
    Hum Vaccin Immunother; 2014; 10(1):170-83. PubMed ID: 24064511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Local immunization against P. aeruginosa with an outer-membrane-protein vaccine].
    Grundmann T; Freihorst J; Kubesch P; Tümmler B; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):924-7. PubMed ID: 1763004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
    Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
    APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
    APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U; Mansouri E; von Specht BU
    Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection.
    Thomas LD; Cripps AW; Kyd JM
    Vaccine; 2009 May; 27(25-26):3324-30. PubMed ID: 19200832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia.
    Bertot GM; Restelli MA; Galanternik L; Aranibar Urey RC; Valvano MA; Grinstein S
    Infect Immun; 2007 Jun; 75(6):2740-52. PubMed ID: 17296759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats.
    Johansen HK; Espersen F; Pedersen SS; Hougen HP; Rygaard J; Høiby N
    APMIS; 1993 Mar; 101(3):207-25. PubMed ID: 8507458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia.
    Naito Y; Hamaoka S; Kinoshita M; Kainuma A; Shimizu M; Katoh H; Moriyama K; Ishii KJ; Sawa T
    Microbiol Immunol; 2018 Dec; 62(12):774-785. PubMed ID: 30378708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-linked immunosorbent assay for detection of antibody to Pseudomonas aeruginosa and measurement of antibody titer in horse serum.
    Ueda Y; Sanai Y; Homma JY
    Am J Vet Res; 1982 Jan; 43(1):55-60. PubMed ID: 6807144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against respiratory Pseudomonas aeruginosa infection.
    Grimwood K; Kyd JM; Owen SJ; Massa HM; Cripps AW
    Hum Vaccin Immunother; 2015; 11(1):14-20. PubMed ID: 25483510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
    Meitert T; Meitert E; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
    Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
    Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
    Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
    J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres.
    Pedersen SS; Shand GH; Hansen BL; Hansen GN
    APMIS; 1990 Mar; 98(3):203-11. PubMed ID: 2107827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa.
    Zuercher AW; Horn MP; Wu H; Song Z; Bundgaard CJ; Johansen HK; Høiby N; Marcus P; Lang AB
    Vaccine; 2006 May; 24(20):4333-42. PubMed ID: 16600444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T; Ito E; Nguyen VH; Haight M
    Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas pneumonia of mink: pathogenesis, vaccination, and serologic studies.
    Long GG; Gallina AM; Gorham JR
    Am J Vet Res; 1980 Oct; 41(10):1720-5. PubMed ID: 6784614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.